1. Home
  2. SUPN vs INTA Comparison

SUPN vs INTA Comparison

Compare SUPN & INTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$54.18

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Intapp Inc.

INTA

Intapp Inc.

HOLD

Current Price

$22.39

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
INTA
Founded
2005
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.2B
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
SUPN
INTA
Price
$54.18
$22.39
Analyst Decision
Strong Buy
Buy
Analyst Count
5
8
Target Price
$61.60
$48.63
AVG Volume (30 Days)
781.0K
2.0M
Earning Date
05-21-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
6500.00
48.89
EPS
N/A
N/A
Revenue
$392,755,000.00
$504,120,000.00
Revenue This Year
$8.18
$15.88
Revenue Next Year
$22.15
$13.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.09
52 Week Low
$29.16
$19.24
52 Week High
$59.68
$67.01

Technical Indicators

Market Signals
Indicator
SUPN
INTA
Relative Strength Index (RSI) 60.66 31.68
Support Level $47.95 $20.76
Resistance Level $57.65 $44.05
Average True Range (ATR) 2.13 1.59
MACD 0.49 0.43
Stochastic Oscillator 46.18 44.49

Price Performance

Historical Comparison
SUPN
INTA

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About INTA Intapp Inc.

Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital,g, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.

Share on Social Networks: